» Articles » PMID: 2864579

Malignant Melanoma in Scotland 1979-1983

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 1985 Oct 19
PMID 2864579
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

1318 cases of primary malignant melanoma of the skin first presenting in Scotland in the years 1979-83 and registered with the Scottish Melanoma Group are described. The annual age-adjusted incidence rate is 4.75 per 100 000 for females and 2.77 per 100 000 for males. Incidence rose by an annual average of 2.5% over the five-year period. The female: male ratio was 2:1, and 48.5% of all cases were of the superficial spreading histogenetic variety. Five-year survival rates for the patients registered in 1979 confirm the prognostic value of the tumour-thickness (Breslow) measurement. They were 93% for patients with tumours less than 1.5 mm thick (39% of patients), 67% for those with tumours 1.5-3.49 mm thick (30%), and 37% for those with tumours thicker than 3.5 mm (31%). This study shows that methods for early recognition of thin tumours should be encouraged.

Citing Articles

No association of vitamin D metabolism-related polymorphisms and melanoma risk as well as melanoma prognosis: a case-control study.

Schafer A, Emmert S, Kruppa J, Schubert S, Tzvetkov M, Mossner R Arch Dermatol Res. 2012; 304(5):353-61.

PMID: 22576141 PMC: 3382284. DOI: 10.1007/s00403-012-1243-3.


Melanoma incidence and mortality in Scotland 1979-2003.

Mackie R, Bray C, Vestey J, Doherty V, Evans A, Thomson D Br J Cancer. 2007; 96(11):1772-7.

PMID: 17533392 PMC: 2359933. DOI: 10.1038/sj.bjc.6603801.


Importance of polymorphisms in NF-kappaB1 and NF-kappaBIalpha genes for melanoma risk, clinicopathological features and tumor progression in Swedish melanoma patients.

Bu H, Rosdahl I, Sun X, Zhang H J Cancer Res Clin Oncol. 2007; 133(11):859-66.

PMID: 17492467 DOI: 10.1007/s00432-007-0228-7.


A novel polymorphism in the 1A promoter region of the vitamin D receptor is associated with altered susceptibilty and prognosis in malignant melanoma.

Halsall J, Osborne J, Potter L, Pringle J, Hutchinson P Br J Cancer. 2004; 91(4):765-70.

PMID: 15238985 PMC: 2364794. DOI: 10.1038/sj.bjc.6602006.


Non-melanoma skin cancer and solar keratoses. I. Methods and descriptive results of the South Wales Skin Cancer Study.

Harvey I, Frankel S, Marks R, Shalom D Br J Cancer. 1996; 74(8):1302-7.

PMID: 8883422 PMC: 2075913. DOI: 10.1038/bjc.1996.534.